AIMC Journal:
Expert opinion on therapeutic patents

Showing 1 to 1 of 1 articles

Novel fatty acid amide hydrolase (FAAH) inhibitors: a patent review from 2015 to 2025.

Expert opinion on therapeutic patents
INTRODUCTION: Over the past decade, significant efforts have been made to develop and patent selective fatty acid amide hydrolase (FAAH) inhibitors with favorable pharmacokinetic and safety profiles to modulate pain, inflammation and neurological dis...